Spinal rosette-forming glioneuronal tumor: First case in a young child

Shibayama, Chiaki; Doai, Mariko; Matoba, Munetaka; Morikawa, Mari; Sato, Hitoshi; Okada, Naoki; Saikawa, Yoshiro; Tamase, Akira; Iizuka, Hideaki; Shioya, Akihiro; Yamada, Sohsuke

doi:10.1016/j.radcr.2021.09.052

Cited by 1 publication

(1 citation statement)

References 17 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, Bidinotto et al .,[ 7 ] Hamauchi et al .,[ 15 ] and Shibayama et al . [ 27 ] reported cases of spinal RGNT without FGFR1 mutations. Therefore, RGNT in rare tumor locations may present with various FGFR1 mutation statuses [ Table 2 ].…”

Section: Discussionmentioning

confidence: 99%

Molecular analyses of rosette-forming glioneuronal tumor of the midbrain tegmentum: A report of two cases and a review of the FGFR1 status in unusual tumor locations

Handa

Shibahara

Nakano³

et al. 2022

Surgical Neurology International

View full text Add to dashboard Cite

Background: Rosette-forming glioneuronal tumor (RGNT) is a rare tumor that arises primarily in the posterior fossa, with molecular features of FGFR1 mutation. A previous study reported that brainstem RGNT accounts for only 2.7% cases; therefore, midbrain RGNT is infrequent. Case Description: The authors encountered two cases of RGNT located in the midbrain tegmentum (Case 1: 23-year-old woman and Case 2: 18-year-old boy), both exhibiting similar cystic components with gadolinium-enhanced cyst walls on preoperative magnetic resonance imaging, surgically resected through the occipital transtentorial approach. Histological findings in both cases comprised two characteristic architectures of neurocytic and glial components, typical of RGNT. Molecular assessment revealed no FGFR1 mutation in the initial specimen, but revealed FGFR1 K656E mutation in the recurrent specimen in Case 1 and showed no FGFR1 mutation but showed TERT C228T mutation in Case 2. Neither case revealed IDH1/2, BRAF, H3F3A K27, H3F3A G34, or HIST1H3B K27 mutations. DNA methylation-based classification (molecularneuropathology.org) categorized both cases as RGNT, whose calibrated scores were 0.99 and 0.47 in Cases 1 and 2, respectively. Conclusion: Midbrain tegmentum RGNTs exhibited typical histological features but varied FGFR1 statuses with TERT mutation. RGNT in rare locations may carry different molecular alterations than those in other common locations, such as the posterior fossa.

show abstract

Section: Discussionmentioning

confidence: 99%